Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.

Saved in:
Bibliographic Details
Title: Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.
Authors: Pu T; Digestive Oncology, KU Leuven, Belgium., Peddle AM; Digestive Oncology, KU Leuven, Belgium., Wirapati P; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Tsantoulis P; Geneva University Hospitals, Geneva, Switzerland., Wu Q; Digestive Oncology, KU Leuven, Belgium., Hong Y; Digestive Oncology, KU Leuven, Belgium., Samuel L; Oncology Department, School of Medicine, Medical Sciences and Nutrition, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, UK., Desai J; Peter MacCallum Cancer Centre, Melbourne, Australia., Riener M; Docrates Syöpäsairaala, Helsinki, Finland., Saridaki Z; First Oncology Department, Metropolitan Hospital, Piraeus, Greece.; Asklepios, Oncology Department, Heraklion, Greece., Cunningham D; The Royal Marsden Hospital, London, UK., Tejpar S; Digestive Oncology, KU Leuven, Belgium. sabine.tejpar@uzleuven.be.
Source: NPJ precision oncology [NPJ Precis Oncol] 2026 Jan 13; Vol. 10 (1), pp. 50. Date of Electronic Publication: 2026 Jan 13.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41530374
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pu+T%22">Pu T</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Peddle+AM%22">Peddle AM</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Wirapati+P%22">Wirapati P</searchLink>; Swiss Institute of Bioinformatics, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Tsantoulis+P%22">Tsantoulis P</searchLink>; Geneva University Hospitals, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Wu+Q%22">Wu Q</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Hong+Y%22">Hong Y</searchLink>; Digestive Oncology, KU Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Samuel+L%22">Samuel L</searchLink>; Oncology Department, School of Medicine, Medical Sciences and Nutrition, Aberdeen Royal Infirmary, University of Aberdeen, Aberdeen, UK.<br /><searchLink fieldCode="AU" term="%22Desai+J%22">Desai J</searchLink>; Peter MacCallum Cancer Centre, Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Riener+M%22">Riener M</searchLink>; Docrates Syöpäsairaala, Helsinki, Finland.<br /><searchLink fieldCode="AU" term="%22Saridaki+Z%22">Saridaki Z</searchLink>; First Oncology Department, Metropolitan Hospital, Piraeus, Greece.; Asklepios, Oncology Department, Heraklion, Greece.<br /><searchLink fieldCode="AU" term="%22Cunningham+D%22">Cunningham D</searchLink>; The Royal Marsden Hospital, London, UK.<br /><searchLink fieldCode="AU" term="%22Tejpar+S%22">Tejpar S</searchLink>; Digestive Oncology, KU Leuven, Belgium. sabine.tejpar@uzleuven.be.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101708166%22">NPJ precision oncology</searchLink> [NPJ Precis Oncol] 2026 Jan 13; Vol. 10 (1), pp. 50. <i>Date of Electronic Publication: </i>2026 Jan 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature%22">Springer Nature </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101708166 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2397-768X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222397768X%22">2397768X </searchLink><i>NLM ISO Abbreviation: </i>NPJ Precis Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41530374
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41698-025-01253-5
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 50
    Titles:
      – TitleFull: Exploratory biomarker analysis of RAS/BRAF somatic mutations and gene expression signatures for predicting treatment effects of aflibercept in the velour trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pu T
      – PersonEntity:
          Name:
            NameFull: Peddle AM
      – PersonEntity:
          Name:
            NameFull: Wirapati P
      – PersonEntity:
          Name:
            NameFull: Tsantoulis P
      – PersonEntity:
          Name:
            NameFull: Wu Q
      – PersonEntity:
          Name:
            NameFull: Hong Y
      – PersonEntity:
          Name:
            NameFull: Samuel L
      – PersonEntity:
          Name:
            NameFull: Desai J
      – PersonEntity:
          Name:
            NameFull: Riener M
      – PersonEntity:
          Name:
            NameFull: Saridaki Z
      – PersonEntity:
          Name:
            NameFull: Cunningham D
      – PersonEntity:
          Name:
            NameFull: Tejpar S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 13
              M: 01
              Text: 2026 Jan 13
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2397-768X
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ precision oncology
              Type: main
ResultId 1